|
C14ORF169 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.2380000014598E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.22840000393865E-08 |
| Normal-vs-Stage2 |
1.25350000046431E-07 |
| Normal-vs-Stage3 |
3.29079985483816E-10 |
| Normal-vs-Stage4 |
2.804400E-01 |
| Stage1-vs-Stage2 |
1.900790E-01 |
| Stage1-vs-Stage3 |
2.925800E-01 |
| Stage1-vs-Stage4 |
4.817800E-01 |
| Stage2-vs-Stage3 |
5.793600E-01 |
| Stage2-vs-Stage4 |
2.632200E-01 |
| Stage3-vs-Stage4 |
3.359800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79200000394175E-08 |
| Normal-vs-AfricanAmerican |
1.328480E-02 |
| Normal-vs-Asian |
3.725200E-01 |
| Caucasian-vs-AfricanAmerican |
3.748300E-02 |
| Caucasian-vs-Asian |
6.495000E-01 |
| AfricanAmerican-vs-Asian |
8.917400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.59130000182617E-08 |
| Normal-vs-Female |
6.0549999999937E-05 |
| Male-vs-Female |
2.842000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.282130E-03 |
| Normal-vs-Age(41-60Yrs) |
2.173000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.39890005029986E-10 |
| Normal-vs-Age(81-100Yrs) |
6.192200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.292200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.333400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.639000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.870000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.681600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.329200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.804200E-01 |
| Normal-vs-Grade 2 |
2.41030000402986E-08 |
| Normal-vs-Grade 3 |
6.25965945744156E-12 |
| Normal-vs-Grade 4 |
3.910600E-01 |
| Grade 1-vs-Grade 2 |
4.747600E-01 |
| Grade 1-vs-Grade 3 |
2.562800E-01 |
| Grade 1-vs-Grade 4 |
9.324400E-01 |
| Grade 2-vs-Grade 3 |
5.644100E-02 |
| Grade 2-vs-Grade 4 |
4.581000E-01 |
| Grade 3-vs-Grade 4 |
2.599000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.85285120579692E-12 |
| Normal-vs-ccB subtype |
1.6772000011045E-08 |
| ccA subtype-vs-ccB subtype |
6.949800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.027700E-04 |
| Normal-vs-N1 |
2.97809999993959E-07 |
| N0-vs-N1 |
8.966400E-02 |
|
|
